Author

Edwin H Lin

Observed name: Edwin Lin

Institution: Huntsman Cancer Institute

Observed institutions: Mayo Clinic, Huntsman Cancer Institute

OpenAlex ID: A5102519476

Exploring the potential of combination immune checkpoint strategies in non-small cell lung cancer (NSCLC).

2023 · Aakash Desai, Vivek Subbiah, et al. · Journal of Clinical Oncology · 5

Treatment (Rx) patterns and outcomes with second-line (2L) therapy in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC) treated with cabozantinib plus nivolumab (cabo+nivo) or lenvatinib plus pembrolizumab (len+pem) in first-line (1L).

2026 · Ethan Murdock, Yeonjung Jo, et al. · Journal of Clinical Oncology · 1

Works count: 2

Citation count: 6

H-index: 1

I10-index: